Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU)
Description
The investment seeks to track the performance of the S&P Biotechnology Select Industry Index. The LABU ETF contains constituents. It is focused on growth holdings in the region.
Price $6.13 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | |
| Expense ratio | 1.02% |
| Average spread | 0.816% |
| 1Y roundtrip cost | 1.836% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -45.8% | -15.0% | -5.5% | -48.1% | -28.5% | 15.8% | 24.2% | 3.7% | -19.2% | -12.6% | -131.0% | ||
| 2021 | 25.6% | -12.5% | -28.5% | -0.2% | -20.0% | 16.9% | -25.7% | 21.1% | -16.6% | -3.4% | -20.4% | -15.3% | -79.0% |
| 2020 | -19.3% | -2.3% | -50.3% | 63.7% | 31.4% | 22.5% | -9.6% | 4.3% | -4.4% | 0.4% | 61.1% | 15.9% | 113.5% |
| 2019 | 50.9% | 18.8% | 1.9% | -18.8% | -21.7% | 31.9% | -8.5% | -19.7% | -16.2% | 20.4% | 48.3% | 4.3% | 91.5% |
| 2018 | 29.2% | -11.7% | -10.5% | -6.0% | 30.7% | -2.7% | -1.7% | 15.0% | -13.2% | -47.0% | 3.5% | -35.4% | -49.9% |
| 2017 | 28.5% | 25.4% | -5.4% | 8.5% | -16.0% | 45.1% | 2.6% | 20.8% | 9.4% | -10.3% | -2.6% | 4.4% | 110.3% |
| 2016 | -66.1% | -17.8% | 16.6% | 10.7% | 20.6% | -22.9% | 48.8% | -11.2% | 30.9% | -40.6% | 31.1% | -17.5% | -17.5% |
| 2015 | 16.5% | 0.9% | -37.7% | -45.8% | 18.5% | 23.1% | -11.0% | -35.6% | |||||
| 3.0% | -15.1% | -81.8% | 9.8% | -3.4% | 123.0% | 30.9% | -3.7% | -75.1% | -74.7% | 144.1% | -54.5% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 0.11 | 0.04 | 0.01 | 0.01 | 0.16 | ||||||||
| 2018 | 0.02 | 0.10 | 0.10 | 0.21 | |||||||||
| 2017 | 0.13 | 0.13 | |||||||||||
| 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.23 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Goldman Sachs Trust Financial Square Treasury Instruments Fund Institutional | 17.23% |
| Dreyfus Government Cash Management Funds Institutional | 13.14% |
| Chemocentryx, Inc. | 1.20% |
| Ocugen Inc | 0.88% |
| bluebird bio, Inc. | 0.70% |
| Acceleron Pharma Inc | 0.70% |
| Global Blood Therapeutics Inc | 0.69% |
| Kodiak Sciences, Inc. | 0.65% |
| Karuna Therapeutics, Inc. | 0.63% |
| Cytokinetics, Incorporated | 0.63% |
| Seagen, Inc. | 0.62% |
| Avid Bioservices, Inc. | 0.61% |
| Dynavax Technologies Corporation | 0.61% |
| Mirati Therapeutics Inc. | 0.61% |
| Blueprint Medicines Corp. | 0.61% |
| Top 15 Weights | 39.51% |
Compare with similar ETFs
| LABU | IBBJ | SPAK | SPXZ | SUBZ | TMAT | |
|---|---|---|---|---|---|---|
| Product name | Direxion Daily S&P Biotech Bull 3x Shares ETF | Defiance Nasdaq Junior Biotechnology ETF | Defiance Next Gen SPAC Derived ETF | Morgan Creek - Exos SPAC Originated ETF | Roundhill Streaming Services & Technology ETF | Main Thematic Innovation ETF |
| Issuer | Direxion | Defiance | Defiance | Morgan Creek | Roundhill | Main Funds |
| Price | $6.13 | $29.87 | $14.63 | $11.005 | $7.4295 | $11.832 |
| Expense Ratio | 1.02% |  0.45% | 0.45% | 1% | 0.75% |  1.49% |
| Average Spread | 0.816% | 0.301% | 0.273% | 0.363% | 0.404% | 0.507% |
| AUM | $84,101,600 | $7,270,600 | $26,239,200 | $10,689,600 | $15,633,800 | $42,137,300 |
| Shares | 13,719,677 | 243,408 | 1,793,522 | 971,338 | 2,104,283 | 3,561,301 |
| Average Daily Volume | 56,154,969 | 2,561 | 8,459 | 1,935 | 10,872 | 19,827 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2015-05-28 | 2020-08-03 | 2020-09-30 | 2021-01-20 | 2021-02-10 | 2021-01-29 |
| Index Tracked | S&P Biotechnology Select Industry Index | NASDAQ Junior Biotechnology Index | Indxx SPAC & NextGen IPO Index | No Underlying Index | No Underlying Index | No Underlying Index |
| Category | Leveraged Equities | Health & Biotech Equities | All Cap Equities | Financials Equities | Technology Equities | n/a |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Mid/Small Caps | Large/Mid/Small Caps | Large/Mid/Small Caps | |||
| Value or Growth | Growth | Growth | Blend | Growth | ||
| Region | North America | North America | North America | North America | North America | |
| Countries | U.S. | U.S. | U.S. | U.S. | Broad | Broad |
| Annual Dividend Rate | $0 | $0 | $0 | $0 | $0 | $0.024 |
| Annual Dividend Yield | 0.000% | 0.000% | 0.000% | 0.000% | 0.000% | 0.002% |
| Number of Holdings | 231 | 0 | 0 | 38 | 780 | |
| YTD Return | -82.97% | 0.00% | -31.01% | -30.55% | -17.91% | -42.16% |
| Beta | -0.96 | 0.51 | -0.08 | 0.26 | -1.10 | 0.95 |
| Upside Beta | -1.34 | 1.06 | -0.82 | -0.91 | -1.04 | -1.15 |
| Downside Beta | -0.14 | 0.62 | -0.74 | -0.80 | -0.41 | -1.21 |
| Volatility 1Y | 135.98% | 29.75% | 27.28% | 29.99% | 32.87% | 39.38% |
| Sharpe Ratio 3Y | -0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Treynor Ratio 3Y | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |